期刊文献+

丙戊酸钠对人肾癌ACHN细胞增殖的抑制作用及其机制探讨

Inhibitory effect of valproate on proliferation of human kidney carcinoma ACHN cells and its mechanism
原文传递
导出
摘要 目的:探讨丙戊酸钠(valproate,VPA)对人肾癌ACHN细胞的增殖、细胞周期及凋亡的影响及其可能机制。方法:采用CCK-8法观察VPA对肾癌ACHN细胞的增殖抑制作用。FCM法检测VPA对肾癌ACHN细胞周期和细胞凋亡的影响。实时荧光定量PCR法检测细胞周期调节因子cyclin E1和P^21WAF1以及凋亡调控因子Bcl-2和Bax的m RNA表达。结果:不同浓度的VPA作用于肾癌ACHN细胞48h后均能显著抑制细胞增殖,其半数抑制浓度(50% inhibitory concentration,IC_50)为4.21mmol/L。VPA处理组与对照组相比,G_0/G_1细胞所占比例增加,细胞凋亡率明显增加。4mmol/LVPA处理细胞48h后,cyclin E1 mRNA表达水平明显降低,P^21WAF1mRNA表达量明显增加,Bcl-2mRNA表达水平明显降低,Bax mRNA表达量明显增加。结论:VPA通过诱导细胞周期阻滞和细胞凋亡,抑制肾癌ACHN细胞增殖。 Objective: To investigate the effects of VPA (valproate) on proliferation, cell cycle distribution and apoptosis of human kidney carcinoma ACHN cells and the possible underlying mechanisms. Methods:The effect of VPA on the proliferation of ACHN cells was examined by CCK-8 (cell counting kit-8) assay. Flow cytometry was used to analyze the cell cycle distribution and apoptosis of ACHN cells exposed to VPA. The mRNA expressions of cyclin E1, P^21WAF1, Bcl-2 and Bax were detected by real-time fluorescence quantitative-PCR. Results: Incubation with various concentrations of VPA for 48 h resulted in a significant inhibition of proliferation of ACHN cells with an IC50 (50% inhibitory concentration) value of 4.21 mmol/L. After treatment with VPA, the cell cycle was arrested obviously at G0/G1 phase and the apoptotic rate was significantly increased as compared with the control group. After treatment with 4 mmol/L VPA for 48 h, the levels of P^21WAF1 and Bax mRNAs were both significantly increased, and at the same time, the levels of cyclin E1 and Bcl-2 mRNAs were obviously decreased. Conclusion: VPA can inhibit the proliferation of kidney carcinoma ACHN cells by inducing cell-cycle arrest and apoptosis.
出处 《肿瘤》 CAS CSCD 北大核心 2013年第3期229-233,共5页 Tumor
关键词 肾肿瘤 丙戊酸 细胞增殖 细胞周期 细胞凋亡 Kidney neoplasms Valproic acid Cells proliferation Cell cycles Apoptosis
  • 相关文献

参考文献16

  • 1JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics, 2006[J]. CA Cancer J Clin, 2006, 56(2):106-130.
  • 2FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. IntJ Cancer, 2010, 127(12):2893-291 7.
  • 3TAKAI N, DESMONDJ C, KUMAGAI T, eta/. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells[J]. C/in Cancer Res, 2004, 10(3):1141-1149.
  • 4LI X N, SHU Q, SU J M, et al. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC[J]. Mol Cancer Ther, 2005, 4(12):1912-1922.
  • 5DICKSON B J, GILESTRO G F. Regulation of commissural axon pathfinding by slit and itsRobo receptors[J]. Annu Rev Cell Dev Biol, 2006, 22:651-675.
  • 6MARIADASON J M. HDACs and HDAC inhibitors in colon cancer[J]. Epigenetics, 2008, 3(1): 28-37.
  • 7杨丰强,邵阳,郭长城,施菊妹,郑军华.丙戊酸钠上调人肾癌细胞MICA/B的表达并增强自然杀伤细胞的抗肿瘤活性[J].肿瘤,2012,32(9):689-695. 被引量:5
  • 8EL-DEIRY W S, TOKINO T, VELCULESCU V E, et al. WAF1, a potential mediator of p53 tumor suppression[J]. Cell, 1 993, 75(4):81 7-825.
  • 9GO-I-ILICHER M, MINUCCI S, ZHU P, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells[J]. EMBOJ, 2001,20(24):6969-6978.
  • 10赵蕾,张志华,赵立双,朱翠敏,田文亮,郝长来.丙戊酸钠对Kasumi-1细胞株细胞周期的影响[J].山东医药,2008,48(29):22-24. 被引量:4

二级参考文献17

  • 1郝长来,唐克晶,陈森,邢海燕,王敏,王建祥.5-氮杂脱氧胞苷增强苯丁酸钠对Kasumi-1细胞的诱导分化和凋亡作用[J].中华肿瘤杂志,2005,27(3):148-151. 被引量:8
  • 2JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics, 2006[J].CA Cancer J Clin, 2006, 56(2):106-130.
  • 3FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. IntJ Cancer, 2010, 1 27(1 2):2893-291 7.
  • 4ARMEANU S, KRUSCH M, BALTZ K M, ef al. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma[J]. CUn Cancer Res, 2008, 14(11):3520-3528.
  • 5DICKSON B J, GILESTRO G F. Regulation of commissural axon pathfinding by slit and its Robo receptors[J].Annu Rev Cell Dev Biol, 2006,22:651-675.
  • 6SAKAJIRI S, KUMACAI T,KAWAMATA N,et al. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines[J]. Hematol,2005, 33(1):53-61.
  • 7ARMEANU S, BITZER M, LAUER U M, et al. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate[J]. Cancer Res, 2005,65(14):6321-6329.
  • 8YAMANEGI K, YAMANE J, KOBAYASHI K, et al. Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicityLl]. Oncol Rep, 2010, 24(6):1621-1627.
  • 9SHABBEER S, KORTENHORST M S, KACHHAP S. et al. Multiple molecular pathways explain the antiproliferative effect of valproic acid on prostate cancer cells in vitro and in wVo[J]. Prostate, 2007, 67(10):1099-1110.
  • 10LICHTENFELS R, BIDDISON W E, SCHULZ H,ef al. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity[J]. J Immunol Methods, 1994,172(2):227-239.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部